loader
Please Wait
Applying Filters...

Minakem Generic APIs Minakem Generic APIs

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about 177Lu Lilotomab Satetraxetan, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    177Lu Lilotomab Satetraxetan

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    2D Structure
    1. Also known as: 177lu-tetraxetan-hh1, 177lu-dota-hh1, Unii-054zp16k2q, 054zp16k2q, Who 10078, Lutetium (lu177) lilotomab satetraxetan
    Molecular Formula
    C30H44LuN7O10S
    Molecular Weight
    871.7  g/mol
    InChI Key
    JKXKGIYHPWESMW-NARNYJRYSA-K
    Lutetium Lu 177 Lilotomab-satetraxetan is a radioconjugate consisting of lilotomab, a murine immunoglobulin G1 (IgG1) antibody directed against the CD37 antigen, conjugated via the chelating agent 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-tetraacetic acid (p-SCN-Bn-DOTA) with potential antineoplastic activities. Upon administration of lutetium Lu 177 lilotomab-satetraxetan, the lilotomab moiety binds to CD37 expressed on certain tumor cells. Upon binding, lutetium Lu 177 lilotomab-satetraxetan delivers a cytotoxic dose of beta radiation to CD37-expressing cells. CD37 is a transmembrane glycoprotein expressed at high-levels on B-cells and to a lesser extent on T-cells and myeloid cells, and is frequently overexpressed in certain B-cell lymphomas.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-2-amino-6-[[4-[[(2R)-1,4,7,10-tetrakis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-2-yl]methyl]phenyl]carbamothioylamino]hexanoate;hydron;lutetium-177(3+)
    2.1.2 InChI
    InChI=1S/C30H47N7O10S.Lu/c31-24(29(46)47)3-1-2-8-32-30(48)33-22-6-4-21(5-7-22)15-23-16-36(19-27(42)43)12-11-34(17-25(38)39)9-10-35(18-26(40)41)13-14-37(23)20-28(44)45;/h4-7,23-24H,1-3,8-20,31H2,(H,38,39)(H,40,41)(H,42,43)(H,44,45)(H,46,47)(H2,32,33,48);/q;+3/p-3/t23-,24+;/m1./s1/i;1+2
    2.1.3 InChI Key
    JKXKGIYHPWESMW-NARNYJRYSA-K
    2.1.4 Canonical SMILES
    [H+].[H+].C1CN(CCN(C(CN(CCN1CC(=O)[O-])CC(=O)[O-])CC2=CC=C(C=C2)NC(=S)NCCCCC(C(=O)[O-])N)CC(=O)[O-])CC(=O)[O-].[Lu+3]
    2.1.5 Isomeric SMILES
    [H+].[H+].C1CN(CCN([C@@H](CN(CCN1CC(=O)[O-])CC(=O)[O-])CC2=CC=C(C=C2)NC(=S)NCCCC[C@@H](C(=O)[O-])N)CC(=O)[O-])CC(=O)[O-].[177Lu+3]
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. 177lu-dota-hh1

    2. 177lu-tetraxetan-tetulomab

    3. 177lu-tetulomab

    4. Betalutin

    5. Tetulomab Tetraxetan Lu-177

    2.2.2 Depositor-Supplied Synonyms

    1. 177lu-tetraxetan-hh1

    2. 177lu-dota-hh1

    3. Unii-054zp16k2q

    4. 054zp16k2q

    5. Who 10078

    6. Lutetium (lu177) Lilotomab Satetraxetan

    7. Lutetium (177lu) Lilotomab Satetraxetan [inn]

    8. Lutetium (lu177) Lilotomab Satetraxetan [usan]

    9. 1453362-90-7

    10. Immunoglobulin G1-kappa, Anti-(homo Sapiens Cd37 (tspan26, Tetraspanin-26)), Mus Musculus Monoclonal Antibody, Lutetium (lu 177) Radiolabelled Satetraxetan (dota Derivative) Conjugate

    2.3 Create Date
    2018-05-07
    3 Chemical and Physical Properties
    Molecular Weight 871.7 g/mol
    Molecular Formula C30H44LuN7O10S
    Hydrogen Bond Donor Count5
    Hydrogen Bond Acceptor Count16
    Rotatable Bond Count12
    Exact Mass871.23080 g/mol
    Monoisotopic Mass871.23080 g/mol
    Topological Polar Surface Area296 Ų
    Heavy Atom Count49
    Formal Charge0
    Complexity1050
    Isotope Atom Count1
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count4
    Post Enquiry
    POST ENQUIRY